AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
CGC   19.90 (-0.55%)
GE   7.29 (+7.21%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
CGC   19.90 (-0.55%)
GE   7.29 (+7.21%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
CGC   19.90 (-0.55%)
GE   7.29 (+7.21%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
AAPL   318.11 (+0.44%)
MSFT   181.81 (+0.13%)
FB   229.14 (-1.32%)
GOOGL   1,420.28 (-0.08%)
CGC   19.90 (-0.55%)
GE   7.29 (+7.21%)
AMD   52.74 (-0.85%)
T   31.85 (+3.34%)
ACB   15.30 (-1.99%)
GILD   74.92 (+2.38%)
DIS   121.53 (+0.48%)
BAC   25.98 (+7.00%)
BA   149.52 (+3.31%)
Log in

NASDAQ:SIBNSI-Bone Stock Price, Forecast & News

$18.02
+0.16 (+0.90 %)
(As of 05/27/2020 04:00 PM ET)
Add
Compare
Today's Range
$17.02
Now: $18.02
$18.48
50-Day Range
$10.56
MA: $15.13
$17.48
52-Week Range
$7.20
Now: $18.02
$23.10
Volume92,154 shs
Average Volume139,610 shs
Market Capitalization$512.31 million
P/E RatioN/A
Dividend YieldN/A
Beta1.32
SI-BONE, Inc., a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.67 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SIBN
CUSIPN/A
CIKN/A
Phone408-207-0700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$67.30 million
Book Value$4.09 per share

Profitability

Net Income$-38,400,000.00

Miscellaneous

Employees183
Market Cap$512.31 million
Next Earnings Date8/4/2020 (Estimated)
OptionableNot Optionable

Receive SIBN News and Ratings via Email

Sign-up to receive the latest news and ratings for SIBN and its competitors with MarketBeat's FREE daily newsletter.

SI-Bone (NASDAQ:SIBN) Frequently Asked Questions

How has SI-Bone's stock been impacted by COVID-19 (Coronavirus)?

SI-Bone's stock was trading at $15.32 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SIBN stock has increased by 17.6% and is now trading at $18.02. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of SI-Bone?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SI-Bone in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for SI-Bone.

When is SI-Bone's next earnings date?

SI-Bone is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for SI-Bone.

How were SI-Bone's earnings last quarter?

SI-Bone Inc (NASDAQ:SIBN) issued its quarterly earnings results on Monday, May, 4th. The company reported ($0.47) earnings per share for the quarter, missing analysts' consensus estimates of ($0.38) by $0.09. The business had revenue of $16.82 million for the quarter, compared to the consensus estimate of $17.98 million. SI-Bone had a negative return on equity of 51.33% and a negative net margin of 60.51%. View SI-Bone's earnings history.

What guidance has SI-Bone issued on next quarter's earnings?

SI-Bone issued an update on its FY 2020 After-Hours earnings guidance on Monday, March, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $80-82 million, compared to the consensus revenue estimate of $81.23 million.

What price target have analysts set for SIBN?

5 analysts have issued 12 month price targets for SI-Bone's stock. Their forecasts range from $20.00 to $27.00. On average, they anticipate SI-Bone's stock price to reach $23.60 in the next twelve months. This suggests a possible upside of 31.0% from the stock's current price. View analysts' price targets for SI-Bone.

Has SI-Bone been receiving favorable news coverage?

News stories about SIBN stock have trended somewhat positive on Wednesday, according to InfoTrie. The research firm rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. SI-Bone earned a daily sentiment score of 1.6 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutSI-Bone.

Are investors shorting SI-Bone?

SI-Bone saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 342,900 shares, an increase of 22.2% from the April 30th total of 280,500 shares. Based on an average daily trading volume, of 262,500 shares, the days-to-cover ratio is presently 1.3 days. Approximately 1.7% of the shares of the company are short sold. View SI-Bone's Current Options Chain.

Who are some of SI-Bone's key competitors?

What other stocks do shareholders of SI-Bone own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SI-Bone investors own include Honeywell International (HON), CVS Health (CVS), Home Depot (HD), Thermo Fisher Scientific (TMO), Verizon Communications (VZ), Alibaba Group (BABA), Cisco Systems (CSCO), CSX (CSX), Altria Group (MO) and Procter & Gamble (PG).

Who are SI-Bone's key executives?

SI-Bone's management team includes the following people:
  • Mr. Jeffrey W. Dunn, CEO, Pres & Chairman (Age 63)
  • Dr. Mark A. Reiley M.D., Founder & Director (Age 68)
  • Ms. Laura A. Francis, Chief Financial Officer (Age 52)
  • Mr. Anthony J. Recupero, Chief Commercial Officer (Age 61)
  • Dr. Scott A. Yerby, Chief Technology Officer (Age 51)

When did SI-Bone IPO?

(SIBN) raised $84 million in an initial public offering on Wednesday, October 17th 2018. The company issued 6,000,000 shares at a price of $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

What is SI-Bone's stock symbol?

SI-Bone trades on the NASDAQ under the ticker symbol "SIBN."

Who are SI-Bone's major shareholders?

SI-Bone's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (5.52%), Orbimed Advisors LLC (4.86%), Driehaus Capital Management LLC (3.90%), Morgan Stanley (2.75%), Morgan Stanley (2.75%) and Wells Fargo & Company MN (2.36%). Company insiders that own SI-Bone stock include Anthony J Recupero, David P Bonita, Jeffrey W Dunn, Laura Francis, Mark A Reiley, Michael A Pisetsky, Scott A Yerby, Skyline Venture Partners V Lp and W Carlton Reckling. View institutional ownership trends for SI-Bone.

Which major investors are selling SI-Bone stock?

SIBN stock was sold by a variety of institutional investors in the last quarter, including Deutsche Bank AG, Squarepoint Ops LLC, Nine Ten Capital Management LLC, UBS Group AG, Victory Capital Management Inc., Victory Capital Management Inc., Spark Investment Management LLC, and Silvercrest Asset Management Group LLC. Company insiders that have sold SI-Bone company stock in the last year include Anthony J Recupero, Jeffrey W Dunn, Laura Francis, Michael A Pisetsky, Scott A Yerby, Skyline Venture Partners V Lp, and W Carlton Reckling. View insider buying and selling activity for SI-Bone.

Which major investors are buying SI-Bone stock?

SIBN stock was purchased by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC, Morgan Stanley, Morgan Stanley, Impax Asset Management Group plc, Wells Fargo & Company MN, JPMorgan Chase & Co., BlackRock Inc., and Geode Capital Management LLC. Company insiders that have bought SI-Bone stock in the last two years include David P Bonita, and Skyline Venture Partners V Lp. View insider buying and selling activity for SI-Bone.

How do I buy shares of SI-Bone?

Shares of SIBN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is SI-Bone's stock price today?

One share of SIBN stock can currently be purchased for approximately $18.02.

How big of a company is SI-Bone?

SI-Bone has a market capitalization of $512.31 million and generates $67.30 million in revenue each year. The company earns $-38,400,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis. SI-Bone employs 183 workers across the globe.

What is SI-Bone's official website?

The official website for SI-Bone is www.si-bone.com.

How can I contact SI-Bone?

SI-Bone's mailing address is 471 EL CAMINO REAL SUITE 101, SANTA CLARA CA, 95050. The company can be reached via phone at 408-207-0700 or via email at [email protected]

This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.